ITRM
$1.13
Iterum Therapeutics Plc
($.03)
(2.59%)
ITRM
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.04)
Revenue:  N/A
Thursday
Aug 5
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ITRM reports earnings?
Beat
Meet
Miss

Where is ITRM's stock price going from here?
Up
Flat
Down
Stock chart of ITRM
Analysts
Summary of analysts' recommendations for ITRM
Score
Grade
Pivots
Resistance
$1.27
$1.22
$1.17

$1.13

Support
$1.08
$1.03
$0.99
Tweet
Growth
Description
Iterum Therapeutics plc is a clinical-stage pharmaceutical company. It develops and markets therapies to address unmet medical needs, as well as provides anti-infectives to treat multi-drug resistant pathogens. The company's product pipeline consists of uncomplicated urinary tract infections, complicated urinary tract infections and complicated intra abdominal infections. Iterum Therapeutics plc is based in Dublin, Ireland.